Total Payments
$18,310
2024 Payments
$9,788
Companies
31
Transactions
495
Medicare Patients
3,694
Medicare Billing
$483,109
Payment Breakdown by Category
Food & Beverage$10,892 (59.5%)
Other$5,350 (29.2%)
Travel$1,718 (9.4%)
Education$350.77 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,892 | 479 | 59.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,350 | 4 | 29.2% |
| Travel and Lodging | $1,718 | 6 | 9.4% |
| Education | $350.77 | 6 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $8,784 | 60 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,135 | 161 | $0 (2024) |
| Pulmonx Corporation | $1,772 | 11 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $734.08 | 5 | $0 (2024) |
| Amgen Inc. | $621.67 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $548.01 | 39 | $0 (2024) |
| Mylan Specialty L.P. | $543.82 | 32 | $0 (2024) |
| Insmed, Inc. | $446.73 | 25 | $0 (2024) |
| GENZYME CORPORATION | $401.75 | 19 | $0 (2024) |
| Inspire Medical Systems, Inc. | $267.49 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,788 | 167 | AstraZeneca Pharmaceuticals LP ($6,794) |
| 2023 | $3,713 | 157 | Pulmonx Corporation ($1,060) |
| 2022 | $1,659 | 91 | GlaxoSmithKline, LLC. ($390.66) |
| 2021 | $2,859 | 72 | AstraZeneca Pharmaceuticals LP ($738.84) |
| 2020 | $256.28 | 7 | GlaxoSmithKline, LLC. ($135.13) |
| 2018 | $34.86 | 1 | GlaxoSmithKline, LLC. ($34.86) |
All Payment Transactions
495 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Immunology | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Pulmonology | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $118.74 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $17.63 | General |
| Category: Medical Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,162 | 1,935 | $622,438 | $155,884 |
| 2022 | 17 | 1,084 | 1,754 | $516,895 | $129,137 |
| 2021 | 16 | 1,199 | 2,092 | $614,796 | $155,417 |
| 2020 | 13 | 249 | 458 | $170,706 | $42,671 |
Total Patients
3,694
Total Services
6,239
Medicare Billing
$483,109
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 199 | 696 | $167,610 | $47,856 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 363 | $157,460 | $39,678 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $57,550 | $14,419 | 25.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 104 | $36,820 | $10,782 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 135 | $41,715 | $10,035 | 24.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 59 | $37,070 | $8,697 | 23.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 70 | 75 | $33,030 | $8,276 | 25.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 78 | 82 | $17,375 | $3,865 | 22.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 78 | 82 | $12,950 | $3,011 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $12,280 | $2,912 | 23.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 78 | 82 | $11,395 | $2,793 | 24.5% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 18 | 18 | $21,303 | $1,693 | 7.9% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 12 | 12 | $10,830 | $1,041 | 9.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 27 | 29 | $1,160 | $287.84 | 24.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 26 | 28 | $840.00 | $206.01 | 24.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 24 | 24 | $840.00 | $202.63 | 24.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 11 | 12 | $2,210 | $129.60 | 5.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 182 | 647 | $151,610 | $39,896 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 191 | $82,965 | $21,290 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 111 | 153 | $47,310 | $11,789 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 76 | 76 | $42,850 | $10,280 | 24.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 46 | $29,760 | $7,803 | 26.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 64 | 67 | $29,770 | $7,606 | 25.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 72 | $24,060 | $6,371 | 26.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 47 | 47 | $18,065 | $4,531 | 25.1% |
About Dr. Scott Ferrara, D.O
Dr. Scott Ferrara, D.O is a Pulmonary Disease healthcare provider based in Lodi, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2014. The National Provider Identifier (NPI) number assigned to this provider is 1710305339.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Ferrara, D.O has received a total of $18,310 in payments from pharmaceutical and medical device companies, with $9,788 received in 2024. These payments were reported across 495 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($10,892).
As a Medicare-enrolled provider, Ferrara has provided services to 3,694 Medicare beneficiaries, totaling 6,239 services with total Medicare billing of $483,109. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Lodi, NJ
- Active Since 04/01/2014
- Last Updated 02/24/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1710305339
Products in Payments
- FASENRA (Biological) $6,514
- ZEPHYR ENDOBRONCHIAL VALVE (Device) $1,309
- TRELEGY ELLIPTA (Drug) $1,061
- BREZTRI (Drug) $1,010
- NUCALA (Biological) $997.30
- TEZSPIRE (Biological) $890.42
- DUPIXENT (Biological) $756.84
- Da Vinci Surgical System (Device) $734.08
- OFEV (Drug) $447.09
- Arikayce (Drug) $446.73
- YUPELRI (Drug) $434.03
- CHARTIS CATHETER (Device) $334.29
- FARXIGA (Drug) $309.22
- INSPIRE (Device) $267.49
- Prolastin-C Liquid (Biological) $240.89
- OPSUMIT (Drug) $217.17
- AIRSUPRA (Drug) $148.32
- (8874) inCourage (Device) $144.90
- ANDEXXA (Biological) $140.30
- XOLAIR (Drug) $137.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.